AYI
Asset Logo

A1 Investments & Resources Ltd

🇦🇺 ASX

💸 FINANCIALS

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-10.00%
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

A1 Investments & Resources Ltd. is a private equity investment company. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-02. The Company’s segments include General investment and Food products and supplements. The General investment segment includes investment operations focusing on diversified investment portfolios. The Food products and supplements segment is engaged in the sale of dried seafood products and supplements. The Company’s projects include Blue Ocean Health and Blue Ocean Japan. The firm also has diversified investments worldwide in the healthcare and resource sectors. Its wholly owned subsidiaries include China Century Capital (HK) Limited, A1 Investments Operations Pty Limited and Blue Ocean Japan Co., Limited.

📈 Performance

Price History

-50.00%

1M

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.00

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in AYI

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in AYI

N/A
AYI investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in AYI also invest in...

Want more shares? Try these...

Global X S&P/ASX 200 Covered Call ETF

AYLD

AYLD.AX was created on 2023-01-30 by Global X. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 52.54m in AUM and 202 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P/ASX BuyWrite Index

📊 Share price

$10.70 AUD

💸 FINANCIALS

🧱 MATERIALS

🇦🇺 AUSTRALIA

Find Out More

Australia United Mining Ltd. engages in gold production and exploration. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2011-09-19. The company holds tenure over two projects in New South Wales and Queensland, both of which contain prospects with targets identified and show evidence of gold production. The company holds a 100% registered interest in three granted mineral tenements of Forsayth Project (ML3417, ML3418, and EPM14498) in Queensland, and a granted exploration license of Sofala Project in New South Wales (EL7423). The Sofala Project is located approximately 30 kilometers (km) north of Bathurst in the central west of New South Wales and covers a portion of Sofala Volcanics and younger sediments on the eastern side of the Hill End Trough. The area is host to many vein style gold occurrences. Forsayth Project is located around and to the south-east of the town of Forsayth in North Queensland within the Forsayth Province of the Georgetown Inlier.

📊 Share price

$0.00 AUD

⛏️ MINING

AXP Energy Ltd. is an oil and gas production and development company, which engages in the exploration, development, and production of oil and gas in the United States of America. The company is headquartered in Lexington, Kentucky. The company went IPO on 2006-07-20. The Company’s segments are defined by geographic area within its Oil & Gas basins in the United States: Appalachian Basin, Denver-Julesburg Basin, Illinois Basin, and Corporate and other. The Appalachian Basin is situated primarily in the Eastern part of Kentucky, Western Virginia and North-Eastern part of Tennessee; these assets are situated in a well-defined gas producing area of the Appalachian Basin. The Denver-Julesburg Basin assets are situated in the historic Florence oilfield and are geologically defined by the Canon City Embayment. The Illinois Basin is spread across Western Kentucky, situated in the heart and prolific section of the basin. Its formations of interest include the Palestine, Waltersburg, Tar Springs, Hardinsburg, Jackson, St. Genevieve, O’Hara, McClosky, Warsaw and Fort Payne. The firm has primary operations in Kentucky, Illinois, Indiana and Colorado.

🙌 Performance (5Yr p.a)

-15.71%

📊 Share price

$0.00 AUD

⚡️ ENERGY

Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). The company is headquartered in Perth, Western Australia. The company went IPO on 2021-11-26. The principal activities of the Company are the development of medical technology using AI to identify patients at risk of coronary artery disease. The company is an applied artificial intelligence healthcare company that works alongside clinicians to improve the diagnosis of coronary heart disease and develop an overview of a patient at risk. The firm has developed deep learning algorithms that allow for the prediction and prevention of acute coronary events. Its Artrya Salix is a computed tomography coronary angiography (CCTA) image analysis solution that enables physicians with AI to identify and analyze the extent and type of arterial plaque. This solution uses no external reading teams to validate cardiac scan data, allowing physicians direct control of their AI-supported patient scans. Artrya Salix provides solutions for physicians, administrators, payers and patients.

📊 Share price

$0.43 AUD

🩺 HEALTH CARE

Compare
Add to watchlist